Target intelligence / Profile preview

Mitochondrial DNA replication machinery (mtDNA replication machinery)

Target
mtDNA replication machinery
Molecular classification
Enzyme, DNA polymerase, Helicase, DNA-binding protein
01

Overview

The mitochondrial DNA (mtDNA) replication machinery, also known as the mitochondrial replisome, is a specialized protein complex responsible for the duplication and maintenance of the mitochondrial genome (PMID: 16352715). The core components of this machinery include the heterotrimeric DNA polymerase gamma (POLG), the hexameric Twinkle DNA helicase (TWNK), and the mitochondrial single-stranded DNA-binding protein (SSBP1) (UniProt: P54098, Q96RR1, Q04837). This system is essential for cellular energy production, as mtDNA encodes 13 critical subunits of the oxidative phosphorylation system (PMID: 27694354). While not typically a primary therapeutic target for activation, it is a major site of off-target toxicity for nucleoside reverse transcriptase inhibitors (NRTIs) used in HIV treatment, which can inhibit POLG and lead to mtDNA depletion (PMID: 11478370). Emerging research also explores the intentional inhibition of this machinery as a strategy to treat certain cancers that exhibit high dependency on mitochondrial function (PMID: 30143515). Mutations in the genes encoding these proteins are linked to a spectrum of mitochondrial diseases, such as Alpers-Huttenlocher syndrome and progressive external ophthalmoplegia (PMID: 15505000).

Other names
Mitochondrial replisomemtDNA replisomeMitochondrial DNA polymerase gamma complexPOLG-TWNK-SSBP1 complex
02

Mechanism of action

Inhibition of DNA polymerase gamma (POLG) by nucleoside analogs, leading to DNA chain termination and depletion of mitochondrial DNA (PMID: 16352715).

03

Biological functions

DNA replicationMitochondrial genome maintenanceCellular energy metabolismOrganelle biogenesis
04

Disease associations

Mitochondrial DNA depletion syndromeCancerHIV/AIDS (drug-induced toxicity)Alpers-Huttenlocher syndromeProgressive external ophthalmoplegiaAtaxia-neuropathy spectrum
05

Safety considerations

Mitochondrial toxicityLactic acidosisPeripheral neuropathyHepatic steatosisMyopathyLipodystrophy
06

Interacting drugs

Zidovudine

7 more in the full profile.

07

Biomarkers

mtDNA copy numberSerum lactate levelsPOLG gene mutationsSSBP1 expression levelsmtDNA/nDNA ratio

Beyond the preview

Go deeper on Mitochondrial DNA replication machinery (mtDNA replication machinery).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial DNA replication machinery (mtDNA replication machinery).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call